CD274 and tuberculosis: To further clarify whether the efficacy of anti-PD-(L)1 therapy was affected by the tuberculosis activity status or anti-tuberculosis therapy, we compared the oncologic outcomes of active tuberculosis patients who received anti-tuberculosis therapy with those diagnosed with latent and obsolete tuberculosis who did not receive anti-tuberculosis therapy.